HAL vs VRDN · P/E 9.3, rev $11.12B vs rev $425.0K
Halliburton Company (HAL) versus Viridian Therapeutics Inc (VRDN) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Viridian Therapeutics Inc (VRDN) is a biotechnology company listed on US.
Latest reported HAL revenue for 2026-06-30 was $11.12B. Net income was $995.0M. HAL currently screens at market cap $19.05B and trailing P/E 9.3.
Latest reported VRDN revenue for 2026-06-30 was $425.0K. Net income was -$232.0M. VRDN currently screens at market cap $1.39B.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. VRDN currently screens at market cap $1.39B.
Not investment advice. Open the HAL and VRDN stock pages for the full models.
Not investment advice.